Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CANVAC DHPPiL + R
- Development stage
- Unknown
- Lead developer
- Dyntec
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
CANVAC DHPPiL + R is an approved veterinary combination vaccine developed by Dyntec spol. s r.o. for the active prophylactic immunization of dogs. It is designed to protect against a broad spectrum of canine pathogens, including canine distemper virus, infectious hepatitis, infectious laryngotracheitis, canine parvovirosis, canine parainfluenza, leptospirosis (caused by serovars L. icterohaemorrhagiae, L. grippotyphosa, and L. sejroe), and rabies. The vaccine is supplied in two parts: a lyophilized component (DHPPiL) containing attenuated live viruses and inactivated Leptospira, and a liquid component (R) containing inactivated rabies virus. Upon reconstitution, the vaccine is administered subcutaneously to stimulate the animal's immune system to produce a protective response against these specific viral and bacterial infections.
- Brand names
- CANVAC DHPPiL + R
- Other names
- CANVAC DHPPiL+R
02
Targets
CPV capsid (Canine parvovirus capsid protein)CAdV-2 (Canine adenovirus type 2)PIV5 (Parainfluenza virus 5)Rabies virus antigen
Beyond the preview
Go deeper on CANVAC DHPPiL + R.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CANVAC DHPPiL + R.